Page 3 - hypertension_newsletter_Special_Servier_final

REFLECTIONS
Hypertension
Hypertension Special Edition – ESH 2024 Highlights

CLINICAL GUIDELINES Hypertension

ESH 2024 Clinical guidelines for the management of arterial hypertension.
Kreutz R, et al. European J of Int Med. Article in Press. June 24, 2024.

The ESH reported in 2023 its current guidelines for the
management of arterial hypertension. While comprehensive,
due to its length and complexity, some GPs and specialists
found it challenging to navigate. Therefore, the ESH decided
to provide, with its 2024 Clinical Practice Guidelines, a
novel concise format that supports the dissemination of the
important information. The ESH developed a MASTERplan
for the management of hypertension.

The MASTERplan provides practical tables and algorithmic
guidance in each of the key topics, including:

• Measure blood pressure – diagnosis
- Recommendations and the use of the different
methods for in- and out-of-office BP measurement
(conditions, posture, measure, and relevance).
• Assess patient
- Recommended basic and advanced assessment
and when to refer a patient to specialist or hospital CLICK HERE
according to the severity of hypertension, clinical FOR THE FULL GUIDELINES
circumstances, and individual needs of patients.
• Select therapy
- Strategy regarding initial management of hypertension, with the aim to control BP within three months according to patient risk.
- Risk stratification according to grade and stage of hypertension.
- Recommended lifestyle interventions together with their relevance and prescribing patterns.
- The general treatment strategy for patients with hypertension.
- Recommended strategy in older persons according to their functional capacities/autonomy status.

• Evaluate response
- Summary of important aspects that should be evaluated and considered during the initiation phase (three months), short-
term (three months to one year) and long-term follow-up (more than one year).

While the successful implementation of the guideline depends on many factors, including national/ regional
opportunities and challenges in healthcare systems, the ESH hopes that this MASTERplan will make a meaningful
contribution to the further development and improvement of hypertension care.

TABLE OF CONTENTS